![ECOG-ACRIN logo[19516]275×75](https://blog-ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
December 23, 2024
The co-chairs reflect on the past year in cancer research and make the case for embracing the inclusion of real-world data in ECOG-ACRIN
December 23, 2024
This major new initiative is a unique opportunity for researchers and patients to help build an important real-world data registry of patients with EGFR-mutated non-small cell lung cancer
November 25, 2024
Fall Group Meeting highlights; impactful results in head and neck cancer; a ComboMATCH update
November 25, 2024
Several themes emerged as key areas of focus for ECOG-ACRIN during the Fall 2024 Group Meeting
October 17, 2024
The co-chairs reflect on how the cancer research landscape has evolved over the last five years
September 17, 2024
This innovative real-world data study is developing an infrastructure to conduct a study comparing outcomes in patients with EGFR-mutated NSCLC receiving osimertinib with or without chemotherapy and not enrolled in a clinical trial
July 3, 2024
GI Cancer Committee displays strong representation at ASCO; real-world data study nears activation; ECOG-ACRIN commends NCI's appointment of senior advisor for clinical research
March 7, 2024
Big data projects near activation; APP Working Group builds momentum; ECOG-ACRIN welcomes Winn CILA scholar
December 19, 2023
The Fall 2023 Group Meeting was notable for a prominent increase in attention to diversity, equity, and inclusion
October 19, 2023
Advanced Practice Providers Working Group debuts soon; community-focused column highlights genetic testing challenges; real-world data efforts accelerate
February 10, 2023
Plans for the year ahead; a focus on data; the future of cancer screening studies
June 21, 2022
Reflections on the spring conference season, including highlights from the Spring Group Meeting and ASCO's Annual Meeting